Phosphonoacetic Acid [clinicaltrials_resource:635df486bbefbb1b9d79baeecd5dc88c]
clinicaltrials:NCT00000134Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) [clinicaltrials:NCT00000136]Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component [clinicaltrials:NCT00000665]A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure [clinicaltrials:NCT00000691]A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir [clinicaltrials:NCT00000697]Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome [clinicaltrials:NCT00000726]A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease [clinicaltrials:NCT00000729]CMV Retinitis Retreatment Trial [clinicaltrials:NCT00000766]A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease. [clinicaltrials:NCT00000856]The Effect of Stomach Acid on Foscarnet [clinicaltrials:NCT00000964]A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir [clinicaltrials:NCT00000970]Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir [clinicaltrials:NCT00000985]A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time [clinicaltrials:NCT00001002]Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS [clinicaltrials:NCT00001061]An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies [clinicaltrials:NCT00002021]An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients [clinicaltrials:NCT00002039]A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) [clinicaltrials:NCT00002125]The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment [clinicaltrials:NCT00002144]Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease [clinicaltrials:NCT00002145]Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study [clinicaltrials:NCT00002146]An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies [clinicaltrials:NCT00002272]A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir [clinicaltrials:NCT00002301]A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS [clinicaltrials:NCT00002432]Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV) [clinicaltrials:NCT00947141]T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant [clinicaltrials:NCT00986557]Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant [clinicaltrials:NCT01199562]Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster [clinicaltrials:NCT02151240]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Phosphonoacetic Acid [clinicaltrials_resource:635df486bbefbb1b9d79baeecd5dc88c]
Bio2RDF identifier
635df486bbefbb1b9d79baeecd5dc88c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:635df486bbefbb1b9d79baeecd5dc88c
identifier
clinicaltrials_resource:635df486bbefbb1b9d79baeecd5dc88c
title
Phosphonoacetic Acid
@en
type
label
Phosphonoacetic Acid [clinicaltrials_resource:635df486bbefbb1b9d79baeecd5dc88c]
@en